Early and Comprehensive Care Bundle in Elderly for Acute Heart Failure: a Stepped Wedge Cluster Randomized Trial
NCT ID: NCT03683212
Last Updated: 2020-07-02
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
503 participants
INTERVENTIONAL
2018-12-10
2019-11-12
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Protocol of Diuretics Use in Congestive Therapy in Heart Failure
NCT03892148
Therapeutic Education Strategy for Patients With Acute Heart Failure
NCT03035123
Acute Heart Failure With Preserved Ejection Fraction - COngestion Discharge Evaluation
NCT04343430
Improving Risk Stratification of Emergency Department Patients With Acute Heart Failure
NCT06065761
Reducing Readmission for Frail Elderly Patients With Decompensated Heart Failure
NCT03246035
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The hypothesis of the Elisabeth Study s is that an early care bundle that comprises early and comprehensive management of symptoms, along with prompt detection and treatment of precipitating factors should improve AHF outcome in elderly patients.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
SEQUENTIAL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Intervention period : early and comprehensive care bundle
Early intensive care bundle
The care bundle comprises a list of items to follow and tick on a handover checklist within 4 hours of ED management:
1. Treatment of the congestion: (international guidelines and recommendations)
2. Treatment of precipitating factors
3. NIV (non-invasive ventilation) if respiratory distress with hypercapnia and pH \< 7.35 in absence of contra indication.
4. Preventive LMWH (low molecular weight heparin) if no pre-existing anticoagulation therapy.
acute heart failure standard therapy
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Early intensive care bundle
The care bundle comprises a list of items to follow and tick on a handover checklist within 4 hours of ED management:
1. Treatment of the congestion: (international guidelines and recommendations)
2. Treatment of precipitating factors
3. NIV (non-invasive ventilation) if respiratory distress with hypercapnia and pH \< 7.35 in absence of contra indication.
4. Preventive LMWH (low molecular weight heparin) if no pre-existing anticoagulation therapy.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* at least one of the following symptoms : acute, or worsening of dyspnea, orthopnea
* one or more of the followings: pulmonary rales, peripheral edema, a chest radiograph or transthoracic echocardiography showing pulmonary vascular congestion signs, increased natriuretic peptides (BNP or NT-pro-BNP).
* Patients affiliated to French social security ("AME excepted")
* Written informed consent signed by the patient / the trustworthy person / family member / close relative, or inclusion in case of emergency and written informed consent will been signed by the patient (if need be by trustworthy person, family member or close relative) as soon as possible (article L1122-1-2 of the French Public Health Code)
Exclusion Criteria
* other obvious cause of acute illness (severe sepsis, ST elevation Myocardial infarction)
* systolic blood pressure less than 100 mmHg
* severe mitral or aortic stenosis, or severe aortic regurgitation
* known chronic kidney injury on dialysis
* shock from any cause
* Time from ED entrance to inclusion \> 6h
* Patient under legal protection measure (tutorship or curatorship) and patient deprived of freedom
75 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Assistance Publique - Hôpitaux de Paris
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Yonathan Freund, Doctor
Role: PRINCIPAL_INVESTIGATOR
Assistance Publique - Hôpitaux de Paris
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Emergency department Hospital Pitié-Salpêtrière
Paris, , France
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Freund Y, Cachanado M, Delannoy Q, Laribi S, Yordanov Y, Gorlicki J, Chouihed T, Feral-Pierssens AL, Truchot J, Desmettre T, Occelli C, Bobbia X, Khellaf M, Ganansia O, Bokobza J, Balen F, Beaune S, Bloom B, Simon T, Mebazaa A. Effect of an Emergency Department Care Bundle on 30-Day Hospital Discharge and Survival Among Elderly Patients With Acute Heart Failure: The ELISABETH Randomized Clinical Trial. JAMA. 2020 Nov 17;324(19):1948-1956. doi: 10.1001/jama.2020.19378.
Freund Y, Gorlicki J, Cachanado M, Salhi S, Lemaitre V, Simon T, Mebazaa A. Early and comprehensive care bundle in the elderly for acute heart failure in the emergency department: study protocol of the ELISABETH stepped-wedge cluster randomized trial. Trials. 2019 Jan 31;20(1):95. doi: 10.1186/s13063-019-3188-8.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2018-A01139-46
Identifier Type: OTHER
Identifier Source: secondary_id
K170918J
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.